
Population pharmacokinetics of piperacillin/tazobactam in critically ill Korean patients and the effects of extracorporeal membrane oxygenation
Author(s) -
Yong Kyun Kim,
Hyoung Soo Kim,
Sunghoon Park,
Hwan Il Kim,
Sun Hee Lee,
Donghwan Lee
Publication year - 2022
Publication title -
the journal of antimicrobial chemotherapy/journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkac059
Subject(s) - piperacillin/tazobactam , extracorporeal membrane oxygenation , critically ill , medicine , pharmacokinetics , piperacillin , population pharmacokinetics , tazobactam , population , meropenem , oxygenation , intensive care medicine , pharmacology , anesthesia , antibiotics , microbiology and biotechnology , biology , bacteria , pseudomonas aeruginosa , antibiotic resistance , genetics , environmental health
To explore extracorporeal membrane oxygenation (ECMO)-related alterations of the pharmacokinetics (PK) of piperacillin/tazobactam and determine an optimal dosage regimen for critically ill adult patients.